GUARDANT HEALTH INC (GH)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About GUARDANT HEALTH INC
Guardant Health, Inc. develops blood- and tissue-based cancer testing and related research tools in the healthcare diagnostics business. Listed on NASDAQ as GH, the company generated $982.0 million of revenue in FY2025 from precision-oncology assays, biopharma services, and supporting platforms used in the United States and abroad.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
GUARDANT HEALTH INC's Technical Indicators Summary
GH is rated Strong Buy on consistent momentum, rising moving averages and supportive volume metrics. The stock trades above its short-, medium- and long-term averages, MACD and Momentum are positive, and ADX above 30 signals a meaningful trend. OBV shows accumulation while ATR indicates moderate intraday movement around 4.8%, and VWAP/pivot levels are close but do not negate the prevailing directional bias. Technical takeaway: trend-confirming momentum and broad moving-average support underpin a strong buy technical posture.
| Indicator | Value |
|---|---|
Momentum (10) | 19.99 |
MFI | 65.27 |
RSI (14) | 58.51 |
Stochastic %K (14, 3, 3) | 68.85 |
CCI (20) | 89.29 |
WPR (14) | -35.06 |
MACD Level (12, 26) | 4.80 |
Bollinger Bands | $139.86 - $171.26 |
ATR (14) | $7.94 (4.84%) |
ADX (14) | 30.81 |
OBV | 97,445,800 |
VWAP | $165.41 |
Classic Pivot Point | $165.83 |
Fibonacci Pivot Point | $165.83 |
Exponential Moving Averages | $113.35 - $161.51(5 indicators) |
Simple Moving Averages | $111.16 - $161.86(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
GH shows a slight downside bias, trading -0.66% under yesterday’s close (165.09). Very little stock is changing hands, with volume stuck at 0.24× the everyday baseline. GH raises 2026 revenue guidance after Q2 results, signaling improving growth trajectory.
Trading Volume
Below 10d avg (2.1M)
512.6K
vs S&P 500 Today
Underperforming Market
-0.91%
52-Week Position
Upper range
89.8%
Updated: August 12, 2026 at 17:03 UTC